AzTrials
AzTrials

Lactate Values During Labour in Women Receiving Neuraxial AnaesthesiaNCT06807255

Lactate Values During Labour and Their Correlation With Maternal and Foetal Outcome

An observational study of Lactate Values During Labour in Women Receiving Neuraxial Anaesthesia, run by Papa Giovanni XXIII Hospital at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postpartum haemorrhage (PPH) represents a significant cause of morbidity in the obstetric population, with a mortality rate of 140,000 women per year, and the predominant cause of PPH (70%) is uterine atony. Consequently, elevated lactate levels during labour could influence maternal and foetal well-being. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission
Type of treatment
Injection or infusion
How many people
303 participants
Where
1 siteItaly
Study dates
1 May 2023to 1 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: women in active labour receiving neuraxial anaesthesia

Who may be able to join

  • ≥ 18 years old
  • single pregnancy with a gestational age of ≥ 36 weeks
  • active labour with a cervix dilation of 4 to 6 cm
  • neuraxial analgesia
  • consent to the study Exclusion criteria
  • < 18 years
Show all 11Show fewer
  • twin pregnancy
  • gestational age < 36 weeks,
  • labour without labour analgesia
  • cervix dilation > 6 cm at the moment of the placement of neuraxial analgesia
  • not consent to the study

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • ASST Papa Giovanni XXIII

    Bergamo, 24129

Other trials in Italy

About this study

Official title: Lactate Values During Labour and Their Correlation With Maternal and Foetal Outcome: a Prospective Observational Single-centre Study

Postpartum haemorrhage (PPH) represents a significant cause of morbidity in the obstetric population, with a mortality rate of 140,000 women per year, and the predominant cause of PPH (70%) is uterine atony.

Consequently, elevated lactate levels during labour could influence maternal and foetal well-being. We decided to assess lactate concentrations during labour in women receiving neuraxial anaesthesia and evaluate the association between high lactate levels and adverse maternal and foetal outcomes.

The secondary aims of the study were to assess lactate levels at different stages of labour and investigate whether increased lactate concentrations could influence neonatal cord pH upon delivery.

Read the detailed description

We conducted a prospective observational single-centre study involving women in active labour receiving neuraxial anaesthesia.

Labour analgesia was placed at the beginning of active labour, whose definition follows the NICE guidelines. The labour analgesia technique consisted of standard epidural puncture or dural puncture epidural; the maintenance of analgesia was through clinician intermittent boluses given on maternal request.

Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission.

These measurements were taken at three different time points, as follows: T0: at the time of diagnosis of the active phase of the first stage of labour, T1: at the beginning of the active phase of the second stage of labour, at the beginning of active pushing, and T2: at the time of the delivery, before placenta expulsion.

Postpartum haemorrhage (PPH) has been defined following the definition of the Royal College of Obstetricians and Gynaecologists as a total blood loss ≥ 500 ml.

To measure umbilical cord pH, 1-2 ml of cord blood were taken from the umbilical artery one minute after birth, regardless of clamping.

Being tested
Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission
Keywords
Lactate values during labour,, maternal and foetal outcome, HIFI, myometrial contraction, lactacidemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admissionDiagnostic test

    Lactate levels were assessed via a venous blood gas test utilising an IV cannula already placed in the woman's limb upon admission; subsequent analysis was conducted using rapid processing (under 5 minutes from the pre-test) with the Rapidpoint 500 Systems-Siemens (Siemens, Milano) emogasanalyzer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the primary aim of our study was to assess whether elevated lactate values during labour are associated with an increased risk of PPH

    Postpartum haemorrhage has been defined following the definition of the Royal College of Obstetricians and Gynaecologists as a total blood loss ≥ 500 ml.

    Our population was divided into two groups: those with total blood loss ≤ 500 ml and those with blood loss > 500 ml.

    Measured: two hours

Secondary outcomes (2)
  1. The secondary aims of the study were to assess lactate levels at different stages of labour and investigate whether increased lactate concentrations could influence neonatal cord pH upon delivery

    Measurements were taken at three different time points, as follows: T0: at the time of diagnosis of the active phase of the first stage of labour, T1: at the beginning of the active phase of the second stage of labour, at the beginning of active pushing, and T2: at the time of the delivery, before placenta expulsion.

    Measured: Time of labour

  2. neonatal cord pH upon delivery

    To measure umbilical cord pH, 1-2 ml of cord blood were taken from the umbilical artery one minute after birth, regardless of clamping.

    Measured: five minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2025
  2. Study start1 May 2023
  3. Primary completion30 Sep 2023
  4. Study completion1 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
303 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06807255
Sponsor's protocol ID
REF: no. 751/2023, reg56/23
Status last verified
Feb 2025
First submitted
29 Jan 2025
Last updated
7 Feb 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: If requested by the reviewer, it will be possible to share the anonymised database

Publications

  • Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG. 2017 Apr;124(5):e106-e149. doi: 10.1111/1471-0528.14178. Epub 2016 Dec 16. No abstract available.

    PubMed 27981719
  • Alotaibi M, Arrowsmith S, Wray S. Hypoxia-induced force increase (HIFI) is a novel mechanism underlying the strengthening of labor contractions, produced by hypoxic stresses. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9763-8. doi: 10.1073/pnas.1503497112. Epub 2015 Jul 20.

    PubMed 26195731
  • Hanley JA, Weeks A, Wray S. Physiological increases in lactate inhibit intracellular calcium transients, acidify myocytes and decrease force in term pregnant rat myometrium. J Physiol. 2015 Oct 15;593(20):4603-14. doi: 10.1113/JP270631. Epub 2015 Sep 3.

    PubMed 26223765

Questions about this trial

What is this clinical trial studying?

An observational study of Lactate Values During Labour in Women Receiving Neuraxial Anaesthesia, run by Papa Giovanni XXIII Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the primary aim of our study was to assess whether elevated lactate values during labour are associated with an increased risk of PPH (time frame: two hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06807255, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in